These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9262087)

  • 41. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
    Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B
    Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
    Stevens H; Bakker PF; Schlösser NJ; van Rijk PP; de Klerk JM
    J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer.
    Onal C; Oymak E; Findikcioglu A; Reyhan M
    Int J Gynecol Cancer; 2013 Feb; 23(2):337-42. PubMed ID: 23358181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Mediastinal CT-staging of bronchial carcinomas].
    Hajek P; Imhof H; Kumpan W; Schratter M; Klech H; Moritz E
    Rofo; 1985 Jan; 142(1):74-9. PubMed ID: 2982195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
    Wahl RL; Quint LE; Greenough RL; Meyer CR; White RI; Orringer MB
    Radiology; 1994 May; 191(2):371-7. PubMed ID: 8153308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [F-18 fluorodeoxyglucose positron emission tomography in lung lesions].
    Peschina W
    Wien Med Wochenschr; 2002; 152(11-12):265-8. PubMed ID: 12138653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions.
    Primack SL; Lee KS; Logan PM; Miller RR; Müller NL
    Radiology; 1994 Dec; 193(3):795-800. PubMed ID: 7972827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL; Fischman AJ
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules.
    Fortes DL; Allen MS; Lowe VJ; Shen KR; Wigle DA; Cassivi SD; Nichols FC; Deschamps C
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1223-7. PubMed ID: 18848459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of
    Lopez-Lopez V; Robles R; Brusadin R; López Conesa A; Torres J; Perez Flores D; Navarro JL; Gil PJ; Parrilla P
    Br J Radiol; 2018 Jan; 91(1081):20170216. PubMed ID: 29034693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
    De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
    J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
    Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C
    Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)].
    Sánchez Sánchez R; Rodríguez Fernández A; Gómez Río M; Alkurdi Martínez A; Castellón Rubio VE; Ramos Font C; Sánchez-Palencia Ramos A; Delgado Pérez JR; Llamas Elvira JM
    Rev Esp Med Nucl; 2011; 30(4):211-6. PubMed ID: 21514978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma of the left lung.
    Call S; Rami-Porta R; Serra-Mitjans M; Saumench R; Bidegain C; Iglesias M; Gonzalez-Pont G; Belda J
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1081-4. PubMed ID: 18760928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
    Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
    Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positron emission tomography may underestimate the extent of thoracic disease in lung cancer patients.
    Carnochan FM; Walker WS
    Eur J Cardiothorac Surg; 2009 May; 35(5):781-4; discussion 784-5. PubMed ID: 19272791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Positron emission tomography, bronchogenic carcinoma, and the adrenals.
    Lamki LM
    AJR Am J Roentgenol; 1997 May; 168(5):1361-2. PubMed ID: 9129445
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
    Peng Z; Liu Q; Li M; Han M; Yao S; Liu Q
    Clin Lung Cancer; 2012 Jul; 13(4):312-20. PubMed ID: 22182444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.